Skip to content

Castle Biosciences

US · CSTL #3242 by market cap Listed 2019
33.00 -0.36 -1.08%
Live - 5344 symbols - heartbeat 304s ago · 2026-10-07 19:54
After-hours 33.00 0.00%
Market cap
1.01B
P/B
2.14
EPS
-0.83
Reader sentiment Are you bullish or bearish on CSTL?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/3/3
  • Rating change
    Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $52
    Market Newswire · 2026/5/7
  • Rating change
    CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $40
    Market Newswire · 2026/4/20
  • Rating change
    Guggenheim Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $47
    Market Newswire · 2026/1/26
  • Rating change
    BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/5/13
  • Rating change
    Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $36
    Market Newswire · 2026/7/31
  • Rating change
    Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $43
    Market Newswire · 2026/5/7
  • Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $57
    Market Newswire · 2026/10/1
  • Rating change
    KeyBanc Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $35
    Market Newswire · 2026/5/29
  • Rating change
    Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $52
    Market Newswire · 2026/1/14
  • Rating change
    Guggenheim Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $47
    Market Newswire · 2026/5/7
  • CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/8/3
  • Rating change
    KeyBanc Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/1/30
  • Rating change
    Guggenheim Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $43
    Market Newswire · 2026/1/5
  • Rating change
    CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2025/12/22
  • Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $57
    Market Newswire · 2026/7/31
  • Roth MKM Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/9/22
  • Rating change
    BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $40
    Market Newswire · 2026/5/13
  • Rating change
    Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $44
    Market Newswire · 2026/2/27
  • BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $44
    Market Newswire · 2026/8/3

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.